Study on Biochemical Materials with Development of Hollow and Paclitaxel-Loaded Bubbles for Ultrasound Controlled Drug Release

Article Preview

Abstract:

We report a new type of biochemical materialmultifunctional paclitaxel-loaded poly lactide-lecithin (PLA-lecithin) microbubbles which has been developed with a method of ultrasonic double emulsion solvent evaporation (UDES) combined with lyophilization. Bubbles were characterized to be hollow, well dispersed andwith size of 300nm~2um. Paclitaxel loading efficiency could reach up to 12%, and bubbles with different size and different lecithin content showed varied drug release characteristics but all displayed slow-release and ultrasound controlled properties, illustrating the ultrasound responsive drug release effect of the combination of microbubbles and ultrasound.

You might also be interested in these eBooks

Info:

Periodical:

Pages:

13-16

Citation:

Online since:

September 2013

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2013 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] Unger E, Lund P, Shen D, et al. Nitrogen-filled liposome as a vascular US contrastagent: preliminary evaluation. Radiology 1992; 185: 453-456.

DOI: 10.1148/radiology.185.2.1410353

Google Scholar

[3] Unger E, McCreery T, Sweitzer R, et al. MRX 501: A novel ultrasound contrastagent with therapeutic properties. Acad Radiol 1998; 5(suppl 1): S247-S249.

DOI: 10.1016/s1076-6332(98)80119-0

Google Scholar

[4] K.S. Soppimath, T.M. Aminabhavi, A.R. Kulkarni, W.E. Rudzinski, Biodegradable polymeric nanoparticles as drug delivery devices, J. Control. Release 70 (1–2) (2001) 1–20.

DOI: 10.1016/s0168-3659(00)00339-4

Google Scholar

[5] Margaret A. Wheatley a, *, Flemming Forsberg b. Comparison of in vitro and in vivo acoustic response of a novel 50: 50 PLGA contrast agent. Ultrasonics 44 (2006) 360–367.

DOI: 10.1016/j.ultras.2006.04.003

Google Scholar

[6] Wenjin Cui, 1 Jianzhong Bei, 1 Preparation and Evaluation of Poly(L-lactide-co-glycolide) (PLGA) Microbubbles as a Contrast Agent for Myocardial Contrast Echocardiography. . 2005 Wiley Periodicals, Inc.

DOI: 10.1002/jbm.b.30189

Google Scholar

[7] K. Ferrara, R. Pollard, M. Borden, Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery, Annu. Rev. Biomed. Eng. 9 (2007) 415–447.

DOI: 10.1146/annurev.bioeng.8.061505.095852

Google Scholar

[8] R. Bekeredjian, P.A. Grayburn, R.V. Shohet, Use of ultrasound contrast agents for gene or drug delivery in cardiovascularmedicine, J. Am. Coll. Cardiol. 45 (3) (2005) 329–335.

DOI: 10.1016/j.jacc.2004.08.067

Google Scholar

[9] Phospholipid-stabilized microbubbles: Influence of shell chemistry on cavitation threshold and binding to giant uni-lamellar vesicles. Applied Acoustics 70 (2009) 1313–1322.

DOI: 10.1016/j.apacoust.2008.09.017

Google Scholar

[10] Gregory M. Lanza and Samuel A. Wickline Targeted Ultrasonic Contrast Agents for Molecular Imaging and Therapy. Curr Probl Cardiol 2003; 28: 625-653.

DOI: 10.1016/j.cpcardiol.2003.11.001

Google Scholar